Compounds > farnesol

farnesol and Breast Neoplasms

farnesol has been researched along with Breast Neoplasms in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (35.71)29.6817
2010's6 (42.86)24.3611
2020's3 (21.43)2.80

Authors

AuthorsStudies
Deng, JH; Guan, Y; Huang, QJ; Huang, ZY; Liao, GC; Liu, ZQ; Lu, LL; Pan, DF; Qi, XX; Wang, Y; Yang, ML; Yao, JJ; Zhang, FX; Zhang, YM; Zhuang, XR1
de Dios-Pérez, I; González-Garcinuño, Á; Martín Del Valle, EM1
Al Aboody, MS; Alhoqail, WA; Alothaim, AS; Arulselvan, P; Eraqi, MM; Mickymaray, S; Suresh, K1
Chen, Y; Gao, X; Huang, Y; Li, J; Li, S; Lu, J; Stolz, DB; Sun, M; Venkataramanan, R; Zhang, L; Zhang, X; Zhao, W1
Chen, M; Knifley, T; O'Connor, KL; Spielmann, HP; Subramanian, T1
Chen, Y; Huang, Y; Li, J; Li, S; Venkataramanan, R; Zhang, P; Zhang, X; Zhao, W1
Chordia, MD; Chung, LW; Guan, Y; Li, J; Liu, ZQ; Pan, D; Wang, JP; Xiao, L; Yue, W; Zhang, Y1
Auriola, S; Mönkkönen, H; Mönkkönen, J; Räikkönen, J1
Al-Mahdy, DA; Farag, MA1
Berstein, LM; Harada, H; Lykkesfeldt, AE; Naftolin, F; Santen, RJ; Shanabrough, M; Wang, JP; Yue, W; Zheng, H1
Fan, P; Li, Y; Santen, RJ; Wang, J; Yue, W1
Lynch, AR; McPherson, RA; Neal, LR; Santen, RJ; Yue, W1
Archer, MC; Duncan, RE1
Body, JJ; Chaboteaux, C; Durbecq, V; Journe, F; Larsimont, D; Laurent, G; Nonclercq, D1

Other Studies

14 other study(ies) available for farnesol and Breast Neoplasms

ArticleYear
Ras inhibitor farnesylthiosalicylic acid conjugated with IR783 dye exhibits improved tumor-targeting and altered anti-breast cancer mechanisms in mice.
    Acta pharmacologica Sinica, 2022, Volume: 43, Issue:7

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Farnesol; Female; Humans; Mice; ras Proteins; Salicylates

2022
An Approach to Minimize Tumour Proliferation by Reducing the Formation of Components for Cell Membrane.
    Molecules (Basel, Switzerland), 2022, Apr-24, Volume: 27, Issue:9

    Topics: Breast Neoplasms; Cell Membrane; Cell Proliferation; Cyclodextrins; Farnesol; Female; Humans; Solubility

2022
Chitosan-encapsulated nickel oxide, tin dioxide, and farnesol nanoparticles: Antimicrobial and anticancer properties in breast cancer cells.
    International journal of biological macromolecules, 2023, Sep-01, Volume: 248

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Breast Neoplasms; Cell Line, Tumor; Chitosan; Ciliary Neurotrophic Factor; Farnesol; Female; Humans; Metal Nanoparticles; Spectroscopy, Fourier Transform Infrared

2023
PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.
    Bioconjugate chemistry, 2013, Mar-20, Volume: 24, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Farnesol; Female; HCT116 Cells; Humans; Mice; Mice, Inbred BALB C; Micelles; Paclitaxel; Polyethylene Glycols; Random Allocation; Rats; Salicylates

2013
Use of synthetic isoprenoids to target protein prenylation and Rho GTPases in breast cancer invasion.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Acyclic Monoterpenes; Antineoplastic Agents; Breast Neoplasms; Cell Culture Techniques; Farnesol; Female; Fluorescent Antibody Technique; Humans; Immunoblotting; Molecular Structure; Neoplasm Invasiveness; Protein Prenylation; rho GTP-Binding Proteins; Terpenes

2014
PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.
    Molecular pharmaceutics, 2014, Aug-04, Volume: 11, Issue:8

    Topics: Animals; Breast Neoplasms; Disease Models, Animal; Drug Carriers; Farnesol; Female; HCT116 Cells; Hemolysis; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Micelles; Paclitaxel; Polyethylene Glycols; Salicylates

2014
Improving Therapeutic Potential of Farnesylthiosalicylic Acid: Tumor Specific Delivery via Conjugation with Heptamethine Cyanine Dye.
    Molecular pharmaceutics, 2017, 01-03, Volume: 14, Issue:1

    Topics: Animals; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Carbocyanines; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Farnesol; Female; Humans; MCF-7 Cells; Mice; Mice, Nude; ras Proteins; Salicylates; Tissue Distribution; TOR Serine-Threonine Kinases

2017
Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells.
    Biochemical pharmacology, 2010, Mar-01, Volume: 79, Issue:5

    Topics: Adenosine Triphosphate; Anticarcinogenic Agents; Breast Neoplasms; Cell Line, Tumor; Diphosphonates; Down-Regulation; Drug Screening Assays, Antitumor; Farnesol; Female; Gene Expression Regulation, Neoplastic; Hemiterpenes; Humans; Imidazoles; Mevalonic Acid; Organophosphorus Compounds; Zoledronic Acid

2010
Comparative study of the chemical composition and biological activities of Magnolia grandiflora and Magnolia virginiana flower essential oils.
    Natural product research, 2013, Volume: 27, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Farnesol; Female; Flowers; Humans; Lung Neoplasms; Magnolia; Monocyclic Sesquiterpenes; Oils, Volatile; Phenylethyl Alcohol; Sesquiterpenes; Sesquiterpenes, Germacrane; Species Specificity

2013
New approaches to the understanding of tamoxifen action and resistance.
    Endocrine-related cancer, 2003, Volume: 10, Issue:2

    Topics: Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Farnesol; Female; Humans; Immunoenzyme Techniques; Letrozole; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; Nitriles; Receptors, Estrogen; Salicylates; Tamoxifen; Triazoles; Tumor Cells, Cultured

2003
Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells.
    International journal of cancer, 2005, Dec-10, Volume: 117, Issue:5

    Topics: Apoptosis; Blood; Breast Neoplasms; Cell Division; Cell Line, Tumor; DNA Replication; Enzyme Activation; Epidermal Growth Factor; Estradiol; Farnesol; Humans; Insulin-Like Growth Factor I; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinases; Ribosomal Protein S6 Kinases; Salicylates; Signal Transduction; TOR Serine-Threonine Kinases

2005
Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells.
    Anti-cancer drugs, 2006, Volume: 17, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclodextrins; Dose-Response Relationship, Drug; Estradiol; Farnesol; Female; Humans; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; ras Proteins; Salicylates; Xenograft Model Antitumor Assays

2006
Farnesol induces thyroid hormone receptor (THR) beta1 but inhibits THR-mediated signaling in MCF-7 human breast cancer cells.
    Biochemical and biophysical research communications, 2006, Apr-28, Volume: 343, Issue:1

    Topics: Breast Neoplasms; Cell Line, Tumor; DNA; Farnesol; Gene Expression Regulation; Humans; Response Elements; RNA, Messenger; Signal Transduction; Thyroid Hormone Receptors beta

2006
Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation.
    Breast cancer research and treatment, 2008, Volume: 107, Issue:1

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Farnesol; Gene Silencing; Humans; Ligands; Mevalonic Acid; Microscopy, Fluorescence; Models, Genetic; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Transcription Factors; Transcriptional Activation

2008